CD276 and neoplasm: B7-H3×CD3 BsAbs operationalize this concept; among them, MGD009 is a prototypical candidate engineered for high-affinity binding to both B7-H3 and CD3ε, thereby promoting immunological synapse formation between T cells and tumor cells.